secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-06-02T20:10:13+00:00
Accession:  0001193125-26-253506
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8
--------------------------------------------------------------------------------

- Issued 31,958 and 32,710 common shares to Streeterville on May 26 and June 1, 2026, respectively, in exchange for 3.72 and 4.2 Series Q Preferred shares.
- Shares issued under Section 3(a)(9) exemption; no cash consideration exchanged.
- Annual meeting reconvened June 2 but further adjourned to June 8 for stockholders to review proxy supplement filed May 29.
- Record date remains April 15; stockholders who already voted need not take further action.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/0001193125-26-253506-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/d95782d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-253506

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer